InsidersTradesSigma
Track the VISEN Pharmaceuticals - B share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, VISEN Pharmaceuticals - B has recorded 2 reports. Market capitalisation: €2.2bn. The latest transaction was reported on 28 April 2026 (Sale). Among the most active insiders: LU AN-BANG. Every trade is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,400 of 29,063 companies
10.7
score / 100
Value12
Quality9
FCF yld-20%
Earn yld-11%
EV/EBITDA·
ROE-51%
Gross mgn12%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 April 2026
Declarations2 total
108,750 sharesShareXHKGHKEX:DA20260427E00462
3,500,000 sharesShareXHKGHKEX:DA20260427E00463
2 of 2 declarations
关于 VISEN Pharmaceuticals - B
VISEN Pharmaceuticals - B 是一家专注于医疗保健和制药领域创新疗法开发的公司。该公司在香港证券交易所 (XHKG) 上市。